Venlafaxine induces P-glycoprotein in human Caco-2 cells

Human Psychopharmacology

Volumn 22, Issue 1, 2007, Pages 49-53

  Ehret, M J ^a   Levin, G M ^a   Narasimhan, M ^a   Rathinavelu, A ^a  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

Author keywords

Indinavir; Multi drug resistance gene; P glycoprotein; Rifampin; Venlafaxine

Indexed keywords

CYTOCHROME P450 3A4; GLYCOPROTEIN P; INTESTINE ENZYME; MULTIDRUG RESISTANCE PROTEIN; RIFAMPICIN; VENLAFAXINE;

ARTICLE; BILE; CELL STRAIN CACO 2; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG ELIMINATION; DRUG MECHANISM; DRUG METABOLISM; DRUG TRANSPORT; GENE EXPRESSION; HUMAN; HUMAN CELL; INTESTINE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; RNA ISOLATION;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CACO-2 CELLS; CYCLOHEXANOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG RESISTANCE, MULTIPLE; GENE EXPRESSION; HUMANS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEIN; POLYMERASE CHAIN REACTION; RIFAMPIN;

EID: 33846635987     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.820     Document Type: Article

References (18)

1. Brosen K. 1990. Recent developments in hepatic drug oxidation: implications for clinical pharmacokinetics. Clin Pharmacokinet 18: 220-239.
2. Cole SPC, Bhardwaj G, Gerlach JH, et al. 1992. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258: 1650-1654.
3. Collett A, Tanianis-Hughes J, Warhurst G. 2004. Rapid induction of P-glycoprotein expression by high permeability compounds in colonic cells in vitro: a possible source of transporter mediated drug interactions? Biochem Pharmacol 68: 783-790.
4. Cupp MJ. 1997. Tracy TS. Role of cytochrome P450 3A subfamily in drug interactions. US Pharmacist 22: HS-9-21.
5. Higgins CF. 1992. ABC transporters: from microorganisms to man. Annu Rev Cell Biol 8: 67-113.
6. Hunter J, Jepson MA, Tsuruo T, Simmons NL, Hirst BH. 1993. Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. J Biol Chem 268: 14991-14997.
7. Kim RB. 2002. Drugs as p-glycoprotein substrates, inhibitors, and inducers. Drug Metab Rev 34: 47-54.
8. Levin GM, Nelson LA, DeVane CL, Preston SL, Eisele G, Carson SW. 2001. A pharmacokinetic drug-drug interaction study of venlafaxine and indinavir. Psychopharmacol Bull 35: 62-71.
9. Lin JH, Yamazaki M. 2003. Role of p-glycoprotein in pharmacokinetics. Clin Pharmacokinet 42: 59-98.
10. Magnarin M, Morelli M, Rosati A, Bartoli F, Candussio L, Giraldi T, et al. 2004. Induction of proteins involved in multidrug resistance (P-glycoprotein, MRP1, MRP2, LRP) and of CYP 3A4 by rifampicin in LLC-PK1 cells. Eur J Pharmacol 483: 19-28.
11. Michalets EL. 1998. Update: clinically significant cytochrome P-450 drug interactions. Pharmacotherapy 18: 84-112.
12. Pfunder A, Gutmann H, Beglinger C, Drewe J. 2003. Gene expression of CYP3A4, ABC-transporters (MDR1 and MRP1-MRP5) and hPXR in three different human colon carcinoma cell lines. J Pharm Pharmacol 55: 59-66.
13. Rasband WS. 1997-2005. ImageJ, U.S. National Institutes of Health, Bethesda, Maryland, USA. http://rsb.info.nih.gov/ij/.
14. Schuetz EG, Beck WT, Schuetz JD. 1996a. Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells. Mol Pharmacol 49: 311-318.
15. Schuetz EG, Schinkel AH, Relling MV, Schuetz JD. 1996b. P-glycoprotein: a major determinant of rifampicin-inducible expression of cytochrome P4503A in mice and humans. Proc Natl Acad Sci USA 93: 4001-4005.
16. Slaughter RL, Edwards DJ. 1995. Recent advances: the cytochrome P450 enzymes. Ann Pharmacother 29: 619-624.
17. Weiss J, Dorman SMG, Martin-Facklam M, Kerpen CJ, Ketabi-Kiyanvash N, Haefeli WE. 2003. Inhibition of P-glycoprotein by newer antidepressants. J Pharmacol Exp Ther 305: 197-204.
18. Zaman GJR, Flens MJ, van Leusden MR, et al. 1994. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc Natl Acad Sci 91: 8822-8826.